LynnAKohlmeierMD

Osteoporosis & Bone Metabolism Medicine, Parathyroid, Pituitary Disorders & Neuroendocrinology, Thyroid

Director

Dr. Kohlmeier is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

PubMed

99 citations
Use of Trabecular Bone Score (TBS) as a Complementary Approach to Dual-energy X-ray Absorptiometry (DXA) for Fracture Risk Assessment in Clinical Practice
Enisa Shevroja, Olivier Lamy, Lynn Kohlmeier, Fjorda Koromani, Fernando Rivadeneira
Journal of Clinical Densitometry. 2017-07-01
21 citations
Vertebral fracture risk is reduced in women who lose femoral neck BMD with teriparatide treatment.
Nelson B. Watts, Paul D. Miller, Lynn Kohlmeier, Anthony Sebba, Peiqi Chen
Journal of Bone and Mineral Research. 2009-06-01
3 citations
Patients' preferences for fracture risk communication: the Risk Communication in Osteoporosis (RICO) study.
Charlotte Beaudart, Mitali Sharma, Patricia Clark, Saeko Fujiwara, Jonathan D Adachi
Osteoporosis International. 2024-03-01

A First for Hypoparathyroidism — Yorvipath (Palopegteriparatide) Earns FDA NodAugust 22nd, 2024
FDA OKs Once-Daily Injection for HypoparathyroidismAugust 12th, 2024
Medimaps Group at RSNA 2022: Providing the Full Bone-Health PictureNovember 21st, 2022